The Valley Desk

NCT04971109 · Interventional trial

Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

Overall registry status Completed

Phase 3

Conditions Smallpox

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov